🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting 😲! -> doi.org/10.1111/bju.16… Patients with undetectable pre-RC ctDNA showed an impressive 82% RFS at 21 months! But here's the twist: ctDNA conversion dynamics matter. Not all undetectable MRD cases are the same. Patients who converted from detectable pre-RC ctDNA

Another brilliant manuscript from Reuben Ben-David demonstrating the clinical utility of tumor informed ctDNA, and the fact that not all undetectable ctDNAs are equal. Truly an eye-opening piece of work!!

📝 New Study Highlights: Comparing BCG and Gemcitabine/Docetaxel (Gem/Doce) for Intermediate-Risk #NMIBC As BCG shortages persist, alternative therapies for IR-NMIBC are crucial. Recent data reveals BCG's superiority over Gem/Doce in high-grade RFS and any-grade RFS. Maintenance

Thank you 🙏 YUO for the opportunity to present our work on ctDNA conversion dynamics and undetectable precystectomy ctDNA at the #SUO2024! Conversion dynamics matter and they predict different disease outcomes! Dr. John Sfakianos

Patients undergoing Precision Prostatectomy DO NOT REGRET THEIR DECISION AT ALL!! 97% of patients reported no significant regret. Through this, we hope the voices of the patients are heard. Honored to have worked under Mani Menon on this Firas Abdollah doi.org/10.1002/bco2.4…

So excited to start my training at Cornell!! 😄😄

Treatment decision regret after precision prostatectomy: an analysis of patient-reported outcomes predicting decision regret. #AuthorCommentary ✅ Only 3% of patients report significant regret vs. 25–30% after radical prostatectomy. ✅ 83% experience no regret, thanks to better

Treatment decision regret after precision prostatectomy: an analysis of patient-reported outcomes predicting decision regret. #AuthorCommentary ✅ Only 3% of patients report significant regret vs. 25–30% after radical prostatectomy. ✅ 83% experience no regret, thanks to better

A great time with this team. Dr. John Sfakianos is one of the best Professors I've crossed paths with, very very fortunate to have worked with the team

Grateful to UroToday.com and Rashid K. Sayyid for featuring our article!!

Aaaand another one UroToday.com Rashid K. Sayyid

Dr. Adithya Balasubramanian (Adithya Balasubramanian M.D.) presents a study that evaluated the impact of PCNL settings on patient hospitalization outcomes, post-discharge healthcare utilization, and costs. #AUA25​ Co-authored/funded by Boston Scientific Urology

Recovery of urinary continence after robotic-assisted radical prostatectomy: A multicenter comparison of Retzius-sparing, hood, and standard techniques. Presented by Gal Wald Weill Cornell Medicine Urology. #AUA25 written coverage by Zach Klaassen Georgia Cancer Center on UroToday >

Honored to have won Best Abstract at the #AUA25 on our work in Microultrasound Lesion Resolution in Prostate Cancer patients on Active Surveillance (MP10- 07). I've been guided by the best since Day 1 and owe all this to one man alone, my mentor, Dr. Mani Menon - Mani Menon

UroToday.com Gal Wald Weill Cornell Medicine Urology Zach Klaassen Georgia Cancer Center Kevin Kowalski Georgetown University Urology Journal of Urology 2/2 present study: standard technique red curve 20 month continence denoted by blue X. Nice work Gal Wald NewYork-Presbyterian !

Thanks to the AUA for highlighting our work! Spending more time outside ➡️ increased testosterone Manish Kuchakulla Michael Eisenberg

Had an amazing time at #AUA25 with the Weill Cornell Medicine Urology team! Feeling grateful to be surrounded by such talented, passionate, and supportive co-residents

Honored to secure 3rd place in the Benign Urology category at the New York Section AUA Ferdinand C. Valentine Resident Essay Contest! Grateful for the opportunity to share our work.

A true legend of our field, and one who has guided me more than he knows🙏🙏